Trinity Biotech Plc (TRIB)
1.07
-0.07
(-6.14%)
USD |
NASDAQ |
Dec 11, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Cash from Investing (Quarterly): -1.984M for March 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.2404M |
| Cellectis SA | -3.266M |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.962M |
| Cash from Financing (Quarterly) | 3.815M |
| Free Cash Flow | -19.17M |
| Free Cash Flow Per Share (Quarterly) | -0.2703 |
| Free Cash Flow to Equity (Quarterly) | -12.15M |
| Free Cash Flow to Firm (Quarterly) | -2.633M |
| Free Cash Flow Yield | -139.4% |